Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECP002A (Δ9-THC) in Multiple Sclerosis patients with spasticity and pain
2010-022033-28Phase 2Completed
- Sponsor
- Echo Pharmaceuticals
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium oxybate in multiple sclerosis (MS) (2 arms), sponsored by Echo Pharmaceuticals. Started Oct 2010; status: completed.
02
Drugs
sodium oxybate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2010-022033-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022033-28.